课题基金 / 基金详情

IMMUNE REGULATION BY THE P38 MAP KINASE PATHWAYS

IMMUNE REGULATION BY THE P38 MAP KINASE PATHWAYS
P38 MAP 激酶途径的免疫调节
批准号:
15590434
负责人:
TANAKA Nobuyuki
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

TANAKA Nobuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to analyze the functional significance of the p38 MAP kinase pathways, mkk3 and mkk6 knockout mice were subjected to analysis. To examine the role of the kinases in innate immunity, bone marrow derived macrophages (Mφ) were prepared from mkk3-/-mkk6+/-mice and control mice. When mkk3-/-mkk6+/-derived Mφ were stimulated by LPS, secretion of TNFα as well as IL-12 was severely impaired. Further, inflammatory chemical mediators were also examined. iNOS expression, as judged by the real time RT-PCR, was significantly reduced. These results suggest that p38 MAP kinas pathways play significant roles in innate immunity, polarization of T helper T cells and inflammations. To see if p38 MAP kinase pathways are also involved in cellular apoptosis, a fibloblastoid cell line with mkk3-/-mkk6-/-genotype was generated. This cell line manifested impaired p38 activation upon TNFα stimulation but not by UV exposure, suggesting the possible roles for mkk4 for the residual activation of p38. Apoptosis upon starvation was clearly inhibited in the cells, which corresponded well with the tumorigenic activity of the cell when injected subcutaneously to nude mice. Collectively these results indicated that p38 MAP kinases not only plays role in immune regulation but also in apoptosis and tumor growth. Finally I identified molecules that are phosphorylated by various cytokines with similar kinetics to the p38 MAP kinases, namely STAM1 and Hrs, two molecules involved in vesicular transport. STAM and Hrs forms a tight complex and the degradation of STAM1 was controlled but the presence of Hrs. Since Hrs is expressed in T cells and regulate T cell survival, I concluded that not only p38 but also Hrs and STAMs are involved in immune regulation including T cell survival/apoptosis.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/c2016-1-01662-0
发表时间: 2004
期刊:
影响因子: --
作者: [L. Martini]
通讯作者: L. Martini
Hrs, a Mammalian Master Molecule in Vesicular Transport and Protein Sorting, Suppresses the Degradation of ESCRT Proteins Signal Transducing Adaptor Molecule land 2.
Hrs 是一种哺乳动物囊泡运输和蛋白质分选的主分子,可抑制 ESCRT 蛋白质信号转导接头分子的降解 2。
DOI: --
发表时间: 2005
期刊: The Journal of Biological Chemistry 280
影响因子: --
作者: [H.Kobayashi, N.Tanaka ほか]
通讯作者: N.Tanaka ほか
Nobuyuki Tanaka(他9名): "Mechanism of p38 MAP kinase activation in vivo"Genes & Development. 17・16. 1969-1978 (2003)
Nobuyuki Tanaka(和其他 9 人):“体内 p38 MAP 激酶激活机制”17・16 1969-1978(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1074/jbc.m409969200
发表时间: 2005-03-18
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Kobayashi, H, Tanaka, N, Sugamura, K]
通讯作者: Sugamura, K
6
    Estimating climatic controls of forest plants in East Asia and predicting their distribution changes in the past, present and future
    The role of high-resolution CT in the individual chemotherapheutic treatment for lung cancer
    • 批准号:
      25461826
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2013
    • 负责人:
      TANAKA Nobuyuki
    • 依托单位:
    Development of novel anti-inflammation therapy against deglycosylation of proinflammatory cytokine receptors.
    • 批准号:
      24659183
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Nobuyuki
    • 依托单位:
    The efficacy of renin-angiotensin system blockade for upper tract urothelial carcinoma
    • 批准号:
      24791671
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Nobuyuki
    • 依托单位:
    国内基金
    海外基金
    USP13稳定MKK3调控p38/MAPK信号通路促进结直肠癌进展的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      常思雨
    • 依托单位:
    基于机制导向的新型MKK3抗溃疡性结肠炎小分子抑制剂的设计与药物研究
    • 批准号:
      81903422
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2019
    • 负责人:
      唐美麟
    • 依托单位:
    辣椒素调控MKK3/p38MAPK信号通路抑制鼻咽癌增殖和转移的分子机制
    • 批准号:
      81802705
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2018
    • 负责人:
      徐亚菲
    • 依托单位:
    前列环素类似物调控TGFβ1- MKK3/6-p38MAPKα/β信号通路拮抗糖尿病心肌病的作用机制
    • 批准号:
      81500642
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2015
    • 负责人:
      李洁
    • 依托单位: